Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 2873 entries
View as:

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole

Phase: N/A Priority: Normal
NCT ID: NCT00038038 Org: User:
Start: 01/31/94 End: 06/30/03 Due: 06/30/04

A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02529852 Org: User:
Start: 11/04/15 End: 10/31/22 Due: 10/31/23

Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00738998 Org: User:
Start: 06/05/08 End: 06/28/19 Due: 06/28/20

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04127721 Org: User:
Start: 09/22/20 End: 09/22/20 Due: 09/22/21

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02592356 Org: User:
Start: 11/16/15 End: 03/01/24 Due: 03/01/25

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01277744 Org: User:
Start: 05/09/11 End: 02/16/18 Due: 02/16/19

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01664910 Org: User:
Start: 10/29/12 End: 06/28/23 Due: 06/28/24

Experience of Having Chronic Graft-Versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00353106 Org: User:
Start: 02/28/06 End: 01/31/10 Due: 01/31/11

Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients with Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06584955 Org: User:
Start: 12/31/24 End: 07/31/27 Due: 07/31/28

Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00759798 Org: User:
Start: 08/13/08 End: 07/22/20 Due: 07/22/21

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00516269 Org: User:
Start: 08/31/04 End: 12/31/13 Due: 12/31/14

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

Phase: N/A Priority: Normal
NCT ID: NCT02596711 Org: User:
Start: 11/02/15 End: 08/22/17 Due: 08/22/18

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Phase: N/A Priority: Normal
NCT ID: NCT00506948 Org: User:
Start: 09/30/06 End: 10/31/10 Due: 10/31/11

Active Surveillance in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00490763 Org: User:
Start: 02/13/06 End: 09/06/21 Due: 09/06/22

Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk

Phase: N/A Priority: Normal
NCT ID: NCT03819985 Org: User:
Start: 12/17/18 End: 08/31/27 Due: 08/31/28

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00305643 Org: User:
Start: 02/28/06 End: 10/31/08 Due: 10/31/09

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00301028 Org: User:
Start: 04/30/06 End: 09/30/11 Due: 09/30/12

Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01205672 Org: User:
Start: 09/16/10 End: 05/28/17 Due: 05/28/18

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

Phase: N/A Priority: Normal
NCT ID: NCT06897488 Org: User:
Start: 09/01/25 End: 12/31/30 Due: 12/31/31

Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03222076 Org: User:
Start: 09/28/17 End: 09/14/22 Due: 09/14/23

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00882102 Org: User:
Start: 04/30/09 End: 08/31/12 Due: 08/31/13

A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05120960 Org: User:
Start: 02/27/23 End: 04/12/24 Due: 04/12/25

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

Phase: N/A Priority: Normal
NCT ID: NCT04604509 Org: User:
Start: 08/04/20 End: 12/31/28 Due: 12/31/29

Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06769490 Org: User:
Start: 06/30/25 End: 09/15/30 Due: 09/15/31

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05335941 Org: User:
Start: 06/13/23 End: 09/30/25 Due: 09/30/26